CAPELLO JEFFREY D

CIK 00012241088 companiesNATICK, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001224108

Recent Transactions

50 trades

Exercise/Conversion
NEOGEN CORP$NEOG
Common Stock
2025-10-27$6.19/sh+1,777→ 32,502 total
Exercise/Conversion
NEOGEN CORP$NEOG
Common Stock
2025-10-27$6.19/sh+2,025→ 30,725 total
Exercise/Conversion
NEOGEN CORP$NEOG
Restricted Stock Units
2025-10-27$6.19/sh−2,025→ 4,050 total
Exercise/Conversion
NEOGEN CORP$NEOG
Restricted Stock Units
2025-10-27$6.19/sh−1,777→ 1,777 total
Award
NEOGEN CORP$NEOG
Common Stock
2025-10-23$6.07/sh+19,769→ 48,469 total
Award
NEOGEN CORP$NEOG
Common Stock (Right to Buy)
2025-10-23+50,814→ 50,814 total
Exercise/Conversion
NEOGEN CORP$NEOG
Common Stock
2025-10-07$5.63/sh+2,071→ 28,700 total
Exercise/Conversion
NEOGEN CORP$NEOG
Restricted Stock Units
2025-10-07$5.63/sh−2,071→ 0 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-06-20−2,120→ 0 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-06-20+2,120→ 6,073 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-06-18+2,861→ 2,861 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2025-06-18+15,768→ 15,768 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-06-13+1,977→ 3,953 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-06-13−1,977→ 1,976 total
Purchase
NEOGEN CORP$NEOG
Common Stock
2025-04-22$4.84/sh+20,712→ 26,629 total
Exercise/Conversion
NEOGEN CORP$NEOG
Restricted Stock Units
2024-10-28$13.81/sh−1,776→ 3,552 total
Exercise/Conversion
NEOGEN CORP$NEOG
Common Stock
2024-10-28$13.81/sh+1,776→ 5,917 total
Award
NEOGEN CORP$NEOG
Common Stock (Right to Buy)
2024-10-24+18,653→ 18,653 total
Award
NEOGEN CORP$NEOG
Restricted Stock Units
2024-10-24$13.58/sh+6,075→ 15,840 total
Exercise/Conversion
NEOGEN CORP$NEOG
Common Stock
2024-10-07$15.07/sh+2,070→ 4,141 total
Exercise/Conversion
NEOGEN CORP$NEOG
Restricted Stock Units
2024-10-07$15.07/sh−2,070→ 2,071 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2024-06-20+11,774→ 11,774 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2024-06-20+2,120→ 2,120 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2024-06-13−1,976→ 3,953 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-06-13+1,976→ 1,976 total
Exercise/Conversion
NEOGEN CORP$NEOG
Restricted Stock Units
2023-10-26+5,329→ 9,470 total
Exercise/Conversion
NEOGEN CORP$NEOG
Common Stock (Right to Buy)
2023-10-26+13,716→ 32,132 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2023-06-13+33,177→ 33,177 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2023-06-13+5,929→ 5,929 total
Exercise/Conversion
NEOGEN CORP$NEOG
Restricted Stock Units
2022-10-06+6,212→ 6,212 total
Exercise/Conversion
NEOGEN CORP$NEOG
Common Stock (Right to Buy)
2022-10-06+18,416→ 18,416 total
Exercise/Conversion
BIOGEN INC.$BIIB
Restricted Stock Unit
2020-02-12−1,919→ 10,601 total
Other
BIOGEN INC.$BIIB
Restricted Stock Unit
2020-02-12−2,253→ 8,348 total
Award
BIOGEN INC.$BIIB
Restricted Stock Unit
2020-02-12+10,550→ 10,550 total
Tax Payment
BIOGEN INC.$BIIB
Common Stock
2020-02-12$331.76/sh−614→ 3,118 total
Exercise/Conversion
BIOGEN INC.$BIIB
Common Stock
2020-02-12+1,919→ 3,732 total
Tax Payment
BIOGEN INC.$BIIB
Common Stock
2020-01-02$294.20/sh−406→ 1,813 total
Exercise/Conversion
BIOGEN INC.$BIIB
Common Stock
2020-01-02+1,302→ 2,219 total
Other
BIOGEN INC.$BIIB
Restricted Stock Unit
2020-01-02−1,690→ 2,996 total
Exercise/Conversion
BIOGEN INC.$BIIB
Restricted Stock Unit
2020-01-02−1,302→ 4,686 total
Award
BIOGEN INC.$BIIB
Restricted Stock Unit
2019-02-12+12,520→ 12,520 total
Other
BIOGEN INC.$BIIB
Restricted Stock Unit
2019-01-02−1,661→ 5,988 total
Exercise/Conversion
BIOGEN INC.$BIIB
Restricted Stock Unit
2019-01-02−1,331→ 7,649 total
Tax Payment
BIOGEN INC.$BIIB
Common Stock
2019-01-02$304.69/sh−414→ 917 total
Exercise/Conversion
BIOGEN INC.$BIIB
Common Stock
2019-01-02+1,331→ 1,331 total
Award
Tempest Therapeutics, Inc.$TPST
Stock Option (right to buy)
2018-07-04+12,000→ 12,000 total
Award
BIOGEN INC.$BIIB
Restricted Stock Unit
2018-01-02+8,980→ 8,980 total
Award
BIOGEN INC.$BIIB
Performance Stock Unit
2018-01-02+5,390→ 5,390 total
Award
Salarius Pharmaceuticals, Inc.$SLRX
Stock Option (right to buy)
2017-07-26+12,000→ 12,000 total
Award
Tempest Therapeutics, Inc.$TPST
Stock Option (right to buy)
2017-06-21+12,000→ 12,000 total

Companies

Recent Filings

Address

ONE BOSTON SCIENTIFIC PLACE

NATICK, MA, 01760-1537

View on SEC.gov